Form D · Other

RareCyte, Inc.

Seattle, WA · CIK 0001653064

Offering snapshot reported Jul 25, 2023 · SEC filing

Reported sold
$13.2M
Offering amount: $35.7M
Investors reported
19
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 12, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 25, 2023Initial$13,174,795No comparison19SEC filing
Sep 10, 2021Initial$24,046,147No comparisonNot reportedSEC filing
Dec 26, 2019Initial$22,156,736No comparison0SEC filing
May 24, 2018Initial$4,999,999No comparison1SEC filing
Aug 10, 2017Initial$15,399,995No comparison9SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-487794

Source: Form D, filed Jul 25, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Evan Castiglia Executive
Jim Cooper Executive
Brian Daniels Director
Jan Garfinkle Director
David Kabakoff Director
Eric Kaldjian Executive
Daniel Marshak Director
Stephen Reichenbach Executive
Andrew Schwab Director
Ronald Seubert Director
Robert Shepler Director
Joseph Victor Director, Executive
Joseph J. Victor Jr. Director, Executive
Robert Weisskoff Director
Frank Witney Director

Issuer details

Industry: Other (See others in industry)

Address:
2601 4th Avenue #500
Seattle, WA, 98121